Welcome to our dedicated page for GPGI SEC filings (Ticker: GPGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GPGI, Inc. filings document operating results, investor presentations, dividend actions, proxy matters, governance proposals, and capital-structure disclosures for the company’s multi-industry platform. Form 8-K reports include results of operations and financial condition, Regulation FD disclosures, investor presentation exhibits, and board-approved dividend information.
GPGI’s proxy statements cover annual and special meeting proposals, shareholder voting mechanics, Class A common stock matters, board recommendations, and corporate-governance subjects. The filings also identify the company’s NYSE-listed Class A common stock under the GPGI symbol and provide formal disclosure around shareholder and corporate matters.
Schoen Kurt reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that officer Kurt Schoen received a grant of stock options covering 143,754 shares on the reported date. These options were awarded with no cash paid at grant. They vest in four equal 25% installments on each of the first through fourth anniversaries of the grant date.
Schoen Kurt reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that officer Kurt Schoen received a grant of stock options covering 143,754 shares on the reported date. These options were awarded with no cash paid at grant. They vest in four equal 25% installments on each of the first through fourth anniversaries of the grant date.
Schoen Kurt reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that officer Kurt Schoen received a grant of stock options covering 143,754 shares on the reported date. These options were awarded with no cash paid at grant. They vest in four equal 25% installments on each of the first through fourth anniversaries of the grant date.
Schoen Kurt reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that officer Kurt Schoen received a grant of stock options covering 143,754 shares on the reported date. These options were awarded with no cash paid at grant. They vest in four equal 25% installments on each of the first through fourth anniversaries of the grant date.
GPGI, Inc. reported that insider Thomas R. Knott received a grant of stock options for 1,150,029 shares at an exercise price of $0.00 per share. These options vest in four equal annual installments of 25% on each of the first through fourth anniversaries of the grant date.
GPGI, Inc. reported that insider Thomas R. Knott received a grant of stock options for 1,150,029 shares at an exercise price of $0.00 per share. These options vest in four equal annual installments of 25% on each of the first through fourth anniversaries of the grant date.
GPGI, Inc. reported that insider Thomas R. Knott received a grant of stock options for 1,150,029 shares at an exercise price of $0.00 per share. These options vest in four equal annual installments of 25% on each of the first through fourth anniversaries of the grant date.
GPGI, Inc. reported that insider Thomas R. Knott received a grant of stock options for 1,150,029 shares at an exercise price of $0.00 per share. These options vest in four equal annual installments of 25% on each of the first through fourth anniversaries of the grant date.
COTE DAVID M reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that Executive Chairman David M. Cote received a grant of stock options covering 1,265,032 shares on the reported date. The options were granted at no cost and will vest in four equal annual installments of 25% on each anniversary of the grant date.
COTE DAVID M reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that Executive Chairman David M. Cote received a grant of stock options covering 1,265,032 shares on the reported date. The options were granted at no cost and will vest in four equal annual installments of 25% on each anniversary of the grant date.
COTE DAVID M reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that Executive Chairman David M. Cote received a grant of stock options covering 1,265,032 shares on the reported date. The options were granted at no cost and will vest in four equal annual installments of 25% on each anniversary of the grant date.
COTE DAVID M reported acquisition or exercise transactions in this Form 4 filing.
GPGI, Inc. reported that Executive Chairman David M. Cote received a grant of stock options covering 1,265,032 shares on the reported date. The options were granted at no cost and will vest in four equal annual installments of 25% on each anniversary of the grant date.
Capital Research Global Investors filed a Schedule 13G reporting a significant passive stake in CompoSecure, Inc.. It reports beneficial ownership of 9,213,355 shares of CompoSecure common stock, representing 7.3% of the 126,411,164 shares believed to be outstanding as of 12/31/2025.
The filing states that Capital Research Global Investors has sole voting and sole dispositive power over all 9,213,355 shares, with no shared voting or dispositive power. The position is certified as being held in the ordinary course of business and not for the purpose of changing or influencing control of CompoSecure.
Capital Research Global Investors filed a Schedule 13G reporting a significant passive stake in CompoSecure, Inc.. It reports beneficial ownership of 9,213,355 shares of CompoSecure common stock, representing 7.3% of the 126,411,164 shares believed to be outstanding as of 12/31/2025.
The filing states that Capital Research Global Investors has sole voting and sole dispositive power over all 9,213,355 shares, with no shared voting or dispositive power. The position is certified as being held in the ordinary course of business and not for the purpose of changing or influencing control of CompoSecure.